Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit

Stock News

Yesterday

Jiangsu Cowin Biotech Co.,Ltd. (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration Certificate (In Vitro Diagnostic Reagent) from China's National Medical Products Administration for its self-developed Clostridioides difficile tpi, toxin A, and toxin B gene detection kit (Fluorescent PCR method).

The digestive tract pathogen detection product employs fluorescent PCR technology, targeting specific sequences of the tpi, tcdA, and tcdB genes within the Clostridioides difficile genome. Specific primers and probes are designed for multiplex PCR amplification and detection of these targets.

This kit facilitates the simultaneous detection of tpi, tcdA, and tcdB genes in stool samples, providing auxiliary clinical support for diagnosing Clostridioides difficile infections.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/news/1140666287"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140666287\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140666287?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-15 20:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140666287","market":"fut","top_or_hot":-1,"title":"Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit","media":"Stock News","content":"<p><b>Jiangsu Cowin Biotech Co.,Ltd.</b> (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration Certificate (In Vitro Diagnostic Reagent) from China's National Medical Products Administration for its self-developed Clostridioides difficile tpi, toxin A, and toxin B gene detection kit (Fluorescent PCR method).<br><br>\nThe digestive tract pathogen detection product employs fluorescent PCR technology, targeting specific sequences of the tpi, tcdA, and tcdB genes within the Clostridioides difficile genome. Specific primers and probes are designed for multiplex PCR amplification and detection of these targets.<br><br>\nThis kit facilitates the simultaneous detection of tpi, tcdA, and tcdB genes in stool samples, providing auxiliary clinical support for diagnosing Clostridioides difficile infections.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-15 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Jiangsu Cowin Biotech Co.,Ltd.</b> (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration Certificate (In Vitro Diagnostic Reagent) from China's National Medical Products Administration for its self-developed Clostridioides difficile tpi, toxin A, and toxin B gene detection kit (Fluorescent PCR method).<br><br>\nThe digestive tract pathogen detection product employs fluorescent PCR technology, targeting specific sequences of the tpi, tcdA, and tcdB genes within the Clostridioides difficile genome. Specific primers and probes are designed for multiplex PCR amplification and detection of these targets.<br><br>\nThis kit facilitates the simultaneous detection of tpi, tcdA, and tcdB genes in stool samples, providing auxiliary clinical support for diagnosing Clostridioides difficile infections.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MEDX","symbol_name":"HORIZON KINETICS MEDICAL ETF","start_time":0,"source_url":"","article_id":"1140666287","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140666287","pubTimestamp":1789473999,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Jiangsu Cowin Biotech Co.,Ltd. (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","688426":"康为世纪","MEDX":"HORIZON KINETICS MEDICAL ETF","PCR":"Simplify VettaFi Private Credit Strategy ETF","LNGR":"Global X Longevity Thematic ETF","BK1583":"高瓴概念","BK0239":"医药制造","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","MDEV":"First Trust Indxx Medical Devices ETF","IEIH":"iShares Evolved U.S. Innovative Healthcare ETF","RSPH":"Invesco S&P 500 Equal Weight Health Care ETF","09996":"沛嘉医疗-B","BK1100":"医疗保健设备","GDOC":"Goldman Sachs Future Health Care Equity ETF","AGNG":"Global X Aging Population ETF","PTH":"Invesco Dorsey Wright Healthcare Momentum ETF","BK1574":"生物医药B类股","HART":"NYLI Healthy Hearts ETF"},"translate_title":"江苏冠英生物艰难梭菌检测试剂盒获得III类医疗器械认证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"688426":1,"LNGR":1,"MDEV":1,"MEDX":1,"AGNG":1,"IEIH":1,"HART":1,"LGHT":1,"PCR":1,"RSPH":1,"09996":1,"GDOC":1,"PTH":1},"content_text":"Jiangsu Cowin Biotech Co.,Ltd. (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration Certificate (In Vitro Diagnostic Reagent) from China's National Medical Products Administration for its self-developed Clostridioides difficile tpi, toxin A, and toxin B gene detection kit (Fluorescent PCR method).\nThe digestive tract pathogen detection product employs fluorescent PCR technology, targeting specific sequences of the tpi, tcdA, and tcdB genes within the Clostridioides difficile genome. Specific primers and probes are designed for multiplex PCR amplification and detection of these targets.\nThis kit facilitates the simultaneous detection of tpi, tcdA, and tcdB genes in stool samples, providing auxiliary clinical support for diagnosing Clostridioides difficile infections.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}